Australia's CSL to not go to phase 2 trials for COVID-19 vaccine

Australia's CSL Ltd said on Friday it would not take its COVID-19 vaccine candidate, being developed with the University of Queensland, to phase 2 and 3 clinical trials after trial participants returned false-positive HIV test results.

The biotech giant said it came to the decision with the Australian government to not proceed further.

Also Read: China hikes taxes on Australian wine amid political tension